Objective Patients preoperatively diagnosed with ductal carcinoma in situ (DCIS) by core
needle biopsy (CNB) exhibit a significant risk for upstaging on final pathology, which leads …

BACKGROUND: Some patients who are initially diagnosed with ductal carcinoma in situ
(DCIS) by core biopsy eventually have their disease upstaged to invasive carcinoma on final …

Abstract Background Approximately 8–56% of patients with a core needle biopsy (CNB)
diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive disease at the time …

Objectives To identify preoperative features that could be used to predict invasive breast
cancer in women with a diagnosis of ductal carcinoma in situ (DCIS) at ultrasound (US) …

Background It is desirable to decrease the underestimation rate of invasion in cases
diagnosed as ductal carcinoma in situ (DCIS) in breast core needle biopsy (CNB) in order to …

Background A substantial proportion of women with a pre-operative diagnosis of pure ductal
carcinoma in situ (DCIS) has a final diagnosis of invasive breast cancer (IBC) after surgical …

Background Under-estimation of invasion components occur occasionally at core needle
diagnosed ductal carcinoma in situ (DCIS) that may change the prognosis or treatment …

Background Invasion is often found during postoperative pathological examination of cases
diagnosed as ductal carcinoma in situ (DCIS) by histological examinations such as core …

Purpose Ductal carcinoma in situ (DCIS) is a non-invasive cancerous breast lesion;
however, from 10% to 50% of patients with DCIS diagnosed by core needle biopsy (CNB) or …

Background The major concern over preoperatively diagnosed ductal carcinoma in situ
(DCIS) of breast via ultrasound-guided core needle biopsy (US-CNB) is the risk of missing …